Especially if they come with reductions to Medicaid, food stamps and other safety net programs, the policy will make the rich ...

Novo Nordisk (NVO), the maker of the popular GLP-1 medications Wegovy and Ozempic, said potential tariffs on Europe imposed ...

Despite an intraday bullish recovery, the Euro still chalked in a sixth consecutive session of declines against the Greenback ...

We may have, short-term, a little pain. And people understand that,” President Donald Trump said. That’s how President Trump ...

A radical plan by a former Trump aide seeks to encourage obese Americans to lose weight—by helping their wallet. Robert P.

Police boats have returned to the Potomac River as part of the recovery and investigation after the United States’ deadliest ...

AdvaMed, the largest medical device association globally, urged the Trump administration to exempt medical products from the ...

Diet Coke is having a moment as the drink of choice for Donald Trump, but daily consumption may carry risks, including ...

Shares of weight-loss drug developer Metsera surged nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture Partners-backed biotech firm at $2.68 billion.

Tariffs are paid by US businesses to the government on purchases from abroad and the economic weight can fall on importers, foreign suppliers or consumers.

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...

The US-based Australian sleep apnoea device giant has exceeded expectations with strong second quarter numbers.